ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Therapeutic advances in RRMM: What is the latest on practical application of BCMA-directed therapies?"
Episode Synopsis
touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY
Listen to a series of short expert interviews on the role of B-cell maturation antigen (BCMA)-directed therapies in relapsed/refractory multiple myeloma (RRMM). The faculty discuss patient selection, treatment tailoring and strategies to manage side effects, providing practical guidance for integrating BCMA-targeting approaches into care.
The experts
Prof. Jesús San Miguel, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
Prof. Pieter Sonneveld, Erasmus University Medical Center, Rotterdam, The Netherlands
Dr Francesca Gay, University of Torino, Italy
This touchPODCAST is for HCPs outside of the USA.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our websites: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com
Listen to a series of short expert interviews on the role of B-cell maturation antigen (BCMA)-directed therapies in relapsed/refractory multiple myeloma (RRMM). The faculty discuss patient selection, treatment tailoring and strategies to manage side effects, providing practical guidance for integrating BCMA-targeting approaches into care.
The experts
Prof. Jesús San Miguel, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
Prof. Pieter Sonneveld, Erasmus University Medical Center, Rotterdam, The Netherlands
Dr Francesca Gay, University of Torino, Italy
This touchPODCAST is for HCPs outside of the USA.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our websites: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com
More episodes of the podcast touchPODCAST
Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages
09/10/2025
Phacoemulsification in cataract surgery: Evolving options to optimize refractive outcomes
10/09/2025
In God we trust